NDC 68382-826

Tamoxifen Citrate

Tamoxifen Citrate

Tamoxifen Citrate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Tamoxifen Citrate.

Product ID68382-826_0274f54f-4cbb-42f9-b231-a5d1a24afef9
NDC68382-826
Product TypeHuman Prescription Drug
Proprietary NameTamoxifen Citrate
Generic NameTamoxifen Citrate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-01-03
Marketing CategoryANDA / ANDA
Application NumberANDA206694
Labeler NameZydus Pharmaceuticals (USA) Inc.
Substance NameTAMOXIFEN CITRATE
Active Ingredient Strength10 mg/1
Pharm ClassesEstrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68382-826-01

100 TABLET, FILM COATED in 1 BOTTLE (68382-826-01)
Marketing Start Date2018-01-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68382-826-05 [68382082605]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03
Marketing End Date2019-12-05

NDC 68382-826-77 [68382082677]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03
Marketing End Date2019-12-05

NDC 68382-826-06 [68382082606]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03
Marketing End Date2019-12-05

NDC 68382-826-30 [68382082630]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03
Marketing End Date2019-12-05

NDC 68382-826-16 [68382082616]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03

NDC 68382-826-01 [68382082601]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03

NDC 68382-826-28 [68382082628]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-01-03

NDC 68382-826-14 [68382082614]

Tamoxifen Citrate TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206694
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-01-03

Drug Details

Active Ingredients

IngredientStrength
TAMOXIFEN CITRATE10 mg/1

OpenFDA Data

SPL SET ID:fa87c1c2-f58b-4a12-a658-a957ae7e522d
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 313195
  • 198240
  • Pharmacological Class

    • Estrogen Agonist/Antagonist [EPC]
    • Selective Estrogen Receptor Modulators [MoA]

    Medicade Reported Pricing

    68382082614 TAMOXIFEN 10 MG TABLET

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Tamoxifen Citrate" or generic name "Tamoxifen Citrate"

    NDCBrand NameGeneric Name
    0179-0224Tamoxifen CitrateTamoxifen Citrate
    0378-0144Tamoxifen CitrateTamoxifen Citrate
    0378-0274Tamoxifen CitrateTamoxifen Citrate
    0591-2472Tamoxifen CitrateTamoxifen Citrate
    0591-2473Tamoxifen CitrateTamoxifen Citrate
    50090-0485Tamoxifen CitrateTamoxifen Citrate
    50090-0942Tamoxifen CitrateTamoxifen Citrate
    51407-439Tamoxifen CitrateTamoxifen Citrate
    51407-440Tamoxifen CitrateTamoxifen Citrate
    51862-446Tamoxifen CitrateTamoxifen Citrate
    51862-447Tamoxifen CitrateTamoxifen Citrate
    51862-449Tamoxifen CitrateTamoxifen Citrate
    51862-450Tamoxifen CitrateTamoxifen Citrate
    51862-642Tamoxifen CitrateTamoxifen Citrate
    51862-643Tamoxifen CitrateTamoxifen Citrate
    59651-299Tamoxifen CitrateTamoxifen Citrate
    59651-300Tamoxifen CitrateTamoxifen Citrate
    60429-909Tamoxifen CitrateTamoxifen Citrate
    60429-910Tamoxifen CitrateTamoxifen Citrate
    68382-827Tamoxifen CitrateTamoxifen Citrate
    68382-826Tamoxifen CitrateTamoxifen Citrate
    70518-1881Tamoxifen CitrateTamoxifen Citrate
    70771-1184Tamoxifen CitrateTamoxifen Citrate
    70771-1185Tamoxifen CitrateTamoxifen Citrate
    71335-0237Tamoxifen CitrateTamoxifen Citrate
    71335-0893Tamoxifen CitrateTamoxifen Citrate
    71335-0662Tamoxifen CitrateTamoxifen Citrate
    63187-976Tamoxifen CitrateTamoxifen Citrate
    63739-269Tamoxifen CitrateTamoxifen Citrate
    65084-269Tamoxifen CitrateTamoxifen Citrate
    68071-5005Tamoxifen CitrateTamoxifen Citrate
    71335-1424Tamoxifen CitrateTamoxifen Citrate
    68071-5254Tamoxifen CitrateTamoxifen Citrate
    70518-2721Tamoxifen CitrateTamoxifen Citrate
    51862-682SOLTAMOXTAMOXIFEN CITRATE

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.